Medpace Holdings, Inc.
MEDP
Peringkat dalam Saham
#1303
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Harga Saham
$622.03
Terakhir disinkronkan: 2026-10-20
Kapitalisasi Pasar
$17.36B
Perubahan (1 hari)
0.38%
Perubahan (1 tahun)
14.00%
Negara
US
Perdagangan Medpace Holdings, Inc. (MEDP)
Kategori
Healthcare
Laba untuk Medpace Holdings, Inc. (MEDP)
Laba pada Jun 2026 TTM: $598.92M
Menurut laporan keuangan terbaru dari Medpace Holdings, Inc., laba saat ini perusahaan adalah $598.92M. Pada tahun 2024, perusahaan memperoleh laba sebesar $475.92M, peningkatan dibandingkan laba tahun 2023 sebesar $335.68M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Medpace Holdings, Inc. dari 2013 hingga 2026
Laba pada akhir setiap tahun
| Tahun | Laba | Mengubah |
|---|---|---|
| 2026 (TTM) | $598.92M | 10.43% |
| 2025 | $542.38M | 13.96% |
| 2024 | $475.92M | 41.78% |
| 2023 | $335.68M | 18.67% |
| 2022 | $282.86M | 40.13% |
| 2021 | $201.85M | 19.77% |
| 2020 | $168.53M | 35.01% |
| 2019 | $124.83M | 32.87% |
| 2018 | $93.95M | 64.99% |
| 2017 | $56.95M | 159.35% |
| 2016 | $21.96M | -380.42% |
| 2015 | $-7.83M | -63.17% |
| 2014 | $-21.26M | -154.31% |
| 2013 | $39.15M | 0.00% |
Laba untuk perusahaan serupa atau pesaing
| Perusahaan | Laba | Perbedaan Laba | Negara |
|---|---|---|---|
| $7.61B | 1,170.45% |
US
|
|
| $4.76B | 695.09% |
US
|
|
| $-252.70M | -142.19% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 176.83% |
US
|
